BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25568484)

  • 1. Paroxetine-induced galactorrhea.
    Gulati P; Chavan BS; Das S
    Indian J Psychiatry; 2014 Oct; 56(4):393-4. PubMed ID: 25568484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of galactorrhea during paroxetine treatment.
    Evrensel A; Önen Ünsalver B; Akyol A; Ceylan ME
    Int J Psychiatry Med; 2016 Apr; 51(3):302-5. PubMed ID: 27284122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine.
    Chatterjee SS; Mitra S; Mallik N
    Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):316-8. PubMed ID: 26598592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia.
    Bhattacharjee S; Biswas R; Mandal N
    Indian J Psychiatry; 2021; 63(6):613-616. PubMed ID: 35136264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactorrhea during treatment with trimipramine. A case report.
    Wolfsperger M; Greil W
    Pharmacopsychiatry; 2005 Nov; 38(6):326-7. PubMed ID: 16342006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman.
    Mahasuar R; Majhi P; Ravan JR
    Gen Hosp Psychiatry; 2010; 32(3):341.e11-3. PubMed ID: 20430243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report on azathioprine-induced euprolactinemic galactorrhea.
    Chaudhary D; Jhaj R
    Indian J Pharmacol; 2021; 53(3):234-235. PubMed ID: 34169910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euprolactinemic galactorrhea secondary to domperidone treatment.
    Demir AM; Kuloglu Z; Berberoglu M; Kansu A
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):955-6. PubMed ID: 25781524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of galactorrhea associated with excitalopram.
    Shim SH; Lee YJ; Lee EC
    Psychiatry Investig; 2009 Sep; 6(3):230-2. PubMed ID: 20046401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.
    Camkurt MA; Gülpamuk G; Fındiklı E; Elve R
    Clin Psychopharmacol Neurosci; 2017 May; 15(2):181-183. PubMed ID: 28449567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine-Associated Euprolactinemic Galactorrhea and Hypersexuality: A Case Report and Review of the Literature.
    Warren MB
    J Clin Psychopharmacol; 2016 Aug; 36(4):399-400. PubMed ID: 27219091
    [No Abstract]   [Full Text] [Related]  

  • 13. Galactorrhea induced by paroxetine.
    Morrison J; Remick RA; Leung M; Wrixon KJ; Bebb RA
    Can J Psychiatry; 2001 Feb; 46(1):88-9. PubMed ID: 11221498
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice.
    Umathe SN; Bhutada PS; Jain NS; Mundhada YR; Borkar SS; Dhumal B
    Nitric Oxide; 2009 Sep; 21(2):140-7. PubMed ID: 19584001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
    Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine side effects among psychiatric patients treated with antipsychotics].
    Kovács L; Kovács G
    Neuropsychopharmacol Hung; 2006 Jun; 8(2):61-6. PubMed ID: 17073213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of oncocytic adenoma of the pituitary gland with galactorrhea and hyperprolactinemia].
    Rollet J; Guinet P; Girod C; Trouillas J; Cure M
    Ann Endocrinol (Paris); 1975; 36(4):221-2. PubMed ID: 1239234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.